[Form 4] American Well Corp Insider Trading Activity
Deborah C. Jackson, a director of American Well Corp (AMWL), reported a sale of 4,531 shares of Class A common stock on 09/15/2025 at an average price of $6.5647 per share, leaving her with 39,132 shares beneficially owned directly and 612 shares indirectly held by her spouse.
The filing states the sale was executed under a Rule 10b5-1 trading plan adopted May 20, 2025, and the shares were sold to cover tax liabilities from the vesting and settlement of restricted stock units on June 10, 2025. The Form 4 was signed by an attorney-in-fact on behalf of Ms. Jackson on 09/17/2025.
- Transaction executed under a Rule 10b5-1 plan, indicating pre-established trading terms and reduced risk of opportunistic timing
- Clear explanation that proceeds were used to pay tax liabilities from prior RSU vesting, improving disclosure quality
- Continued meaningful ownership with 39,132 shares held directly after the sale
- Reduction in director's direct holdings by 4,531 shares, which slightly lowers insider ownership
- No information on total percentage ownership relative to outstanding shares, so materiality for investors is unclear
Insights
TL;DR: Director sold a small portion of holdings under a pre-established 10b5-1 plan to cover tax from RSU settlement; routine and non-material.
The reported transaction is a sale of 4,531 shares at $6.5647 executed pursuant to a Rule 10b5-1 plan established May 20, 2025. The filer explains the sale funded tax obligations from RSU vesting on June 10, 2025. As a director-level insider sale undertaken under a pre-set plan and tied to tax obligations, this disclosure is generally considered routine and transparent. The remaining direct beneficial ownership of 39,132 shares indicates continued ownership alignment, while the 612 shares held by spouse are immaterial in size. No derivative positions or additional material transactions are reported.
TL;DR: Governance view: use of a documented 10b5-1 plan and explicit explanation supports compliance and reduces concern about opportunistic timing.
The form clearly notes the 10b5-1 plan adoption date and the purpose of the sale (tax payment for RSU settlement), which is best practice for director trades. The signature by an attorney-in-fact is properly executed. There is no indication of additional planned transactions or amendments. From a governance standpoint this filing reflects adherence to insider trading policies and provides transparent rationale for the sale.